Education
About Us
Working with TipRanks
Follow Us
Cormedix Inc. (CRMD)
:CRMD
Total Valuation
Cormedix has a market cap or net worth of $897.24M. The enterprise value is $347.86M.
Market Cap$897.24M
Enterprise Value$347.86M
Share Statistics
Cormedix has 74,429,170 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding74,429,170
Owned by Insiders2.02%
Owned by Institutions0.66%
Financial Efficiency
Cormedix’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is 0.06%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)0.06%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee679.25K
Profits Per Employee-280.16K
Employee Count64
Asset Turnover0.37
Inventory Turnover0.42
Valuation Ratios
The current PE Ratio of Cormedix is 53.5. Cormedix’s PEG ratio is ―.
PE Ratio53.5
PS Ratio0.00
PB Ratio0.00
Price to Fair Value<0.01
Price to FCF0.00
Price to Operating Cash Flow-54.19
PEG Ratio―
Income Statement
In the last 12 months, Cormedix had revenue of 43.47M and earned -17.93M in profits. Earnings per share was -0.30.
Revenue43.47M
Gross Profit40.28M
Operating Income-22.36M
Pretax Income-19.32M
Net Income-17.93M
EBITDA-18.83M
Earnings Per Share (EPS)-0.30
Cash Flow
In the last 12 months, operating cash flow was -13.57M and capital expenditures -64.60K, giving a free cash flow of -13.63M billion.
Operating Cash Flow-13.57M
Free Cash Flow-13.63M
Free Cash Flow per Share-0.18
Dividends & Yields
Cormedix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.77
52-Week Price Change206.09%
50-Day Moving Average12.59
200-Day Moving Average10.65
Relative Strength Index (RSI)52.34
Average Volume (3m)2.08M
Important Dates
Cormedix upcoming earnings date is Nov 6, 2025, TBA (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
Cormedix as a current ratio of <0.01, with Debt / Equity ratio of 0.41%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap0.00
Net Debt to EBITDA2.13
Interest Coverage Ratio-614.10
Taxes
In the past 12 months, Cormedix has paid -1.39M in taxes.
Income Tax-1.39M
Effective Tax Rate0.07
Enterprise Valuation
Cormedix EV to EBITDA ratio is -23.19, with an EV/FCF ratio of -8.61.
EV to Sales10.05
EV to EBITDA-23.19
EV to Free Cash Flow-8.61
EV to Operating Cash Flow-8.63
Balance Sheet
Cormedix has $77.50M in cash and marketable securities with $476.59K in debt, giving a net cash position of -$77.03M billion.
Cash & Marketable Securities$77.50M
Total Debt$476.59K
Net Cash-$77.03M
Net Cash Per Share-$1.03
Tangible Book Value Per Share$1.41
Margins
Gross margin is 95.19%, with operating margin of -51.43%, and net profit margin of -41.24%.
Gross Margin95.19%
Operating Margin-51.43%
Pretax Margin-44.45%
Net Profit Margin-41.24%
EBITDA Margin-43.32%
EBIT Margin-44.37%
Analyst Forecast
The average price target for Cormedix is $17.38, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$17.38
Price Target Upside40.50% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast―
EPS Growth Forecast64.53%